Question 82

The DEA number of the prescribing provider must be included on the prescription for a Schedule II medication.

A prescription for a Schedule II medication must contain the DEA number of the prescribing provider to validate their authority to prescribe controlled substances. This is a crucial requirement for compliance with federal regulations governing the prescription of these highly regulated medications.

A) National provider identifier (NPI)

The National Provider Identifier (NPI) is not a mandatory requirement on prescriptions for Schedule II medications. While it is used for other healthcare transactions, the DEA number specifically identifies practitioners authorized to prescribe controlled substances, making it more relevant in this context.

B) Controlled substance schedule number

Including the controlled substance schedule number on a prescription for Schedule II medications is not a requirement. The classification as a Schedule II substance is understood in the context of the medication itself, thus making this option incorrect.

C) National Drug Code (NDC)

The National Drug Code (NDC) is used for identifying specific medications but is not mandated on prescriptions for Schedule II drugs. The NDC is more relevant for inventory and billing purposes rather than for authorizing a prescription.

D) DEA number of the prescribing provider

The DEA number of the prescribing provider is essential and legally required on prescriptions for Schedule II medications. This number serves to confirm that the prescriber is licensed to prescribe controlled substances, ensuring adherence to regulatory standards.

Conclusion

The requirement for the DEA number of the prescribing provider on a Schedule II medication prescription is a critical aspect of ensuring compliance with legal regulations. Other options, while relevant in different contexts, do not fulfill the specific requirements outlined for Schedule II prescriptions. Thus, option D is definitively the correct choice.